"Economics in the health system?"

Lectures
Tuesday, March 1 2022| 2:00pm to 4:00pm


Bibliothèque de l'Alcazar

Bruno Ventelou
Only in Frencch | On Tuesday 1 March, Bruno Ventelou (AMSE / CNRS) gave a Sciences Echos conference entitled "Economics in the health system?"
March 02nd 2022
La science économique repose sur un corps de doctrines et de méthodes aux caractéristiques bien précises (rappelées lors de la conférence). Ces doctrines et méthodes semblent difficilement applicables aux questions de santé car « la santé n’a pas de prix », entendons-nous dire souvent. Nous discuterons pourtant de l’intérêt potentiel (et des limites !) du regard de l’économiste dans le champ des pratiques médicales

 

Bruno Ventelou est chercheur au CNRS et membre d'Aix-Marseille School of Economics. Spécialiste de l'économie de la santé, il s'intéresse aux différents systèmes de santé et a travaillé sur les crises sanitaires du VIH sida et de la Covid-19.

Previously issued

  • Dialogues économiques

Sovereign Wealth Funds Still Operating Behind a Smokescreen

What do the purchase of PSG by Qatar, Beijing's influence on New York real estate, and Norway's stakes in Total have in common? These investments are from sovereign wealth funds - investment funds owned by states. Economists Jeanne Amar and Christelle Lecourt have examined the reasons why these funds might seek to have, or continue without, stricter governance.
October 29th 2024
  • Dialogues économiques

Who takes care of the children when their mothers are working?

Is it possible to combine work and family obligations without compromising either? Childcare is an essential factor in the equation. Research by economists Mathieu Lefebvre, Laurène Thil, and Laté A. Lawson reveals how childcare practices vary from country to country, and depend on the mother's socio-economic status.
October 29th 2024
  • Dialogues économiques

Is money in politics good for business?

Economic interests often lie behind the funding of political parties. In the United States, private donations are said to represent a privileged channel through which companies seek favours from the federal government in obtaining public contracts. This is the hypothesis of a team of economic researchers who have looked into the risk of favouritism associated with campaign donations.
October 29th 2024